Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients. Khairallah P, Robbins-Juarez S, Patel S, Shah V, et al. Clin Transplant 2022 Nov 18:e14853. doi: 10.1111/ctr.14853.

Read + Share

Amedeo Smart

Independent Medical Education

Khairallah P, Robbins-Juarez S, Patel S, Shah V, et al. Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients. Clin Transplant 2022 Nov 18:e14853. doi: 10.1111/ctr.14853.
PMID: 36398915